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Aims:  To  determine  patient  and  health  service  factors  associated  with variation  in hospital  mortality
among  resuscitated  cases  of  out-of-hospital  cardiac  arrest  (OHCA)  with  acute  coronary  syndrome  (ACS).
Methods: In this  cohort  study,  we  used  the  Myocardial  Ischaemia  National  Audit  Project  database  to  study
outcomes  in  patients  hospitalised  with  resuscitated  OHCA  due  to  ACS  between  2003  and  2015  in  the
United  Kingdom.  We  analysed  variation  in  inter-hospital  mortality  and used  hierarchical  multivariable
regression  models  to  examine  the  association  between  patient  and  health  service  factors  with  hospital
mortality.
Results:  We  included  17604 patients  across  239  hospitals.  Overall  hospital  mortality  was  28.7%.  In  94
hospitals  that  contributed  at least  60 cases,  mortality  by hospital  ranged  from  10.7%  to  66.3%  (median
28.6%,  IQR  23.2%  to  39.1%)).  Patient  and  health  service  factors  explained  36.1%  of  this  variation.
After  adjustment  for covariates,  factors  associated  with  higher  hospital  mortality  included  increasing
serum  glucose,  ST-Elevation  myocardial  infarction  (STEMI)  diagnosis,  and initial  admission  to a primary
percutaneous  coronary  intervention  (pPCI)  capable  hospital.  Hospital  OHCA  volume  was  not  associated
with  mortality.  The  key  modiﬁable  factor  associated  with  lower  mortality  was early  reperfusion  therapy
in  STEMI  patients.
Conclusion:  There  was  wide  variation  in  inter-hospital  mortality  following  resuscitated  OHCA  due  to ACS
that  was  only partially  explained  by patient  and health  service  factors.  Hospital  OHCA  volume  and  pPCI
capability  were  not  associated  with  lower  mortality.  Early  reperfusion  therapy  was  associated  with  lower
mortality  in  STEMI  patients.
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Introduction
Across Europe, the annual incidence of treated out-of-hospital
cardiac arrest (OHCA) is 49 cases per 100,000 population [1]. Acute
coronary syndrome (ACS) is a common cause of OHCA; where OHCA
cause is recorded, approximately 76% of cases are attributed to car-
diac aetiology [2]. Variation in OHCA mortality has been described
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.
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etween countries, Emergency Medical Service (EMS) systems and
dmitting hospitals [1–3].
Regional cardiac arrest centres have been proposed as a strategy
o reduce inter-hospital variation in OHCA mortality, but the qual-
ty of evidence supporting the concept is low [4,5]. Regionalised
are systems are based on the premise that the beneﬁt of immedi-
te admission to a hospital with specialist facilities and expertise
utweighs any risk associated with a potentially increased trans-
ort time. Such systems are already established in major trauma
nd stroke [6,7].
In OHCA, improved understanding of inter-hospital variation in
ortality is essential to improve understanding of the potential
alue of regionalised care systems. The availability in England and
ales of the only nation-wide ACS registry (Myocardial Ischaemia
ational Audit Project, MINAP) provides a unique opportunity to
etter understand these factors. Our study objective was  to identify
f there was evidence of inter-hospital variation in mortality among
esuscitated cases of OHCA caused by ACS in the UK, and to identify
he patient and health service factors that might contribute to any
ariation.
ethods
ata source
MINAP is a national registry of patients admitted to hospital
ith acute coronary syndromes. Established in 1998, it provides a
echanism for participating hospitals to benchmark performance
gainst national standards [8]. MINAP participation is mandatory,
ith all acute hospitals in England and Wales participating since
003. Detailed care quality and clinical outcome data are collected
t the hospital level, with entry validated through real-time checks
nd an annual hospital data validation review. This study linked
INAP to UK Ofﬁce of National Statistics (ONS) data to provide
nformation on patient social deprivation and enrich mortality data.
INAP identiﬁes patients using their unique NHS number, which is
seudo-anonymised in the database. Patient identiﬁers (for exam-
le, date of birth) are encrypted prior to transfer to the central
atabase, and are not released to researchers.
atient eligibility
In this study, we included adult patients in the MINAP dataset
here the initial cardiac arrest event occurred in the pre-hospital
etting and where initial resuscitation attempts were successful
eading to hospital admission. We  excluded non-index (second or
ubsequent) cardiac arrests, events where the initial cardiac arrest
vent occurred in the in-hospital setting, and patients where the
rimary outcome was unknown.
ata deﬁnitions
For hospital-level data (volume, primary percutaneous coronary
ntervention (pPCI) capability, EMS  distance), patients were cat-
gorised by the hospital to which they were ﬁrst admitted. For
ospital volume, the number of OHCA cases in each year at each
ospital was calculated. Each patient was allocated to a volume
ategory (low: 1–10 cases; medium: 11–24 cases; high: ≥25 cases)
ased on the hospital and year in which they were treated. We  cat-
gorised patients as being treated in a pPCI capable hospital if it
erformed at least 100 pPCI procedures across all patients in the
INAP dataset in the year that the patient was admitted, as per UKuidance [9]. EMS  distance was calculated as the Euclidian distance
etween the patient’s home address and hospital. This assumed the
HCA event occurred at the patient’s home, which is true for over
0% of UK OHCAs [2].on 124 (2018) 49–57
Reperfusion treatment was  categorised as early or late. Throm-
bolysis was  classiﬁed as early if call-to-needle time was  up to
60 min, based on UK national standards [10]. PPCI was  classiﬁed
as early if door-to-balloon time was up to 90 min, based on the
MINAP benchmark [11].
For sub-group analyses, we  categorised patients, based on the
MINAP variable ‘ECG determining treatment,’ as having STEMI (ST-
elevation acute myocardial infarction or presumed new left bundle
branch block (LBBB)) or NSTEACS (non-ST Elevation Acute Coronary
Syndrome, which included all patients that did not meet the STEMI
deﬁnition including unstable angina patients).
Outcome measures
The primary outcome was  all-cause hospital mortality, as
recorded in the MINAP dataset or, where this was incomplete,
cross-referencing with ONS mortality data.
Sample size
Preliminary data supplied by MINAP led to a projected sample
size of 14,310 eligible OHCA cases with a projected hospital mortal-
ity of 24%. Based on this, we  calculated a 4% difference in mortality
between categories within a predictor variable could be detected
reliably with at least 90% power and a signiﬁcance level of 0.05.
Statistical analysis
Multiple imputation using chained equations was used to
reduce the bias associated with missing data in predictor vari-
ables (Supplementary Data Table S1), based on the approach used
in previous MINAP analyses [12,13]. Case identiﬁcation and sub-
group allocation was undertaken prior to imputation. Twenty-ﬁve
imputed datasets were generated.
After imputation, an unadjusted random effects logistic regres-
sion model was ﬁtted to predict hospital mortality and obtain the
estimate for the log of the odds ratio and the standard error for
each imputed dataset. The inclusion of a random effects term for
the hospital enabled variation between hospitals to be modelled.
Estimates from each of the 25 imputed datasets were combined
using the Rubin’s rules to get an overall odds ratio estimate of
mortality, 95% conﬁdence interval and p-value [14]. We adopted a
similar approach for the adjusted analysis. The model included all
clinically relevant predictor variables, unless there was evidence of
multi-collinearity due to two predictors being highly correlated or
a variable was  clearly confounded by an unmeasured variable.
Alongside data from the whole cohort, we report data from
STEMI and NSTEACS sub-groups, and sensitivity analyses (com-
plete case; admission between 2003 and 2008; admission between
2009 and 2015). This sensitivity analysis cut-off reﬂects the year
(2009) that pPCI became the most commonly recorded reperfusion
treatment in MINAP [11].
Data processing and descriptive analyses pre-imputation were
performed using SPSS version 22 (IBM Corp, Armonk, NY, USA). The
R statistical program (R: A language and environment for statistical
computing, R development core team; R Foundation for Statistical
Computing, Vienna, Austria) and associated packages (MICE and
gamm4  packages) were used for multiple imputation, descriptive
analysis after multiple imputation, and ﬁtting models for hospital
mortality.
Ethics/approvalsThe study was undertaken in accordance with the Declaration
of Helsinki. The University of Warwick Biomedical Research Ethics
Committee approved the study. MINAP, as part of the National
K. Couper et al. / Resuscitation 124 (2018) 49–57 51
Fig. 1. Flow chart of case identiﬁcation process.
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esults
tudy population
There were 1,127,140 patient datasets collected by MINAP
etween January 2003 and June 2015 (Fig. 1). Of these, 73,875
6.6%) were identiﬁed as having had a cardiac arrest. Sequential
pplication of study exclusion criteria led to the exclusion of 56,271
atients, most of whom had sustained an in-hospital cardiac arrest
N = 50,836, 90.3%). The study sample included data from 17,604
atients across 239 hospitals. The median number of cases reported
er hospital over the study period was 46 (range 1–517). Neurolog-
cal outcome data were available for 15,286 patients.
The number of cases included annually increased over the study
eriod, with a peak of 2129 cases in 2012 (Supplementary Data Fig.
1).
atient characteristics (whole cohort)
Patients were predominantly male (n = 13,188, 75.1%) with a
ean age of 65.3 years (Table 1). The most common co-morbidity
as hypertension (n = 6389, 41.0%). OHCA events typically occurred
rior to EMS  arrival (n = 10,533, 60.1%) with a shockable pre-
enting rhythm (n = 14,778, 89.6%). Most were classiﬁed as STEMIe cohort, STEMI cases, and NSTEACS cases.
(n = 12,220, 71.9%), and were admitted to the coronary care
(N = 8872, 51.0%) or intensive care (N = 6154, 35.4%) unit. Most
patients received reperfusion therapy (n = 9540, 62.9%), of which
the majority received pPCI (n = 6160, 64.6%). Reperfusion therapy
use increased over time (2003: 20.8%; 2015: 64.1%), with increases
in pPCI use mirrored by a decline in thrombolysis use across all
patients, and in STEMI/NSTEACS sub-groups (Fig. 2). Over the study
period, the percentage of patients admitted to pPCI capable hospi-
tals increased (2003: 0%; 2014: 81%) and the percentage admitted
to low-volume OHCA hospitals decreased (Fig. 3; Supplementary
Data Fig. S2).
Length of stay and patient outcomes
Overall hospital mortality was  28.7% (n = 5047) and 40.9%
(n = 6245) died or were discharged with neurological deﬁcit. In non-
survivors, median time to death was 2 days (IQR 1–5, range 0–96)
(Supplementary Data Fig. S3). For survivors, median length of hos-
pital stay was 7 days (IQR 3–14, range 0–372) (Supplementary Data
Fig. S4).
Variation in inter-hospital mortalityIn the 94 hospitals that contributed at least 60 cases over the
study period, hospital mortality by hospital ranged from 10.7% to
66.3% (median 28.6%, IQR 23.2% to 39.1%) (Supplementary Data Fig.
S5).
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Table  1
Patient characteristics across all cases, STEMI cases and NSTEACS cases.
All cases (n = 17,604)a STEMI (n = 12,220)a NSTEACS (n = 4772)a
Demographic variables
Age (Years)- Mean (SD) 65.3 (13.15) 63.9 (13.06) 68.3 (12.73)
Gender (Female)- n (%) 4370 (24.9) 3034 (24.9) 1155 (24.2)
Ethnicity, n (%)
White 14,343 (93.7) 9927 (93.4) 3904 (94.3)
Asian  531 (3.5) 386 (3.6) 135 (3.3)
Black  131 (0.9) 88 (0.8) 40 (1.0)
Other  303 (2.0) 230 (2.2) 63 (1.5)
Index  of multiple deprivation score- Mean (SD) 22.31 (15.91) 22.27 (15.92) 22.42 (15.94)
Medical history variables- n (%)
Smoking status- Ever smoked 8883 (63.5) 6510 (65.8) 2157 (57.9)
Diabetes status- Diabetic 2158 (13.7) 1283 (11.8) 795 (18.2)
Hypercholesterolaemia- Yes 3906 (25.9) 2600 (24.9) 1197 (28.4)
Heart  failure- Yes 760 (5.0) 356 (3.4) 359 (8.4)
Cerebrovascular disease- Yes 1071 (7.0) 609 (5.7) 419 (9.8)
Previous MI-  Yes 3092 (19.7) 1701 (15.7) 1243 (28.5)
Asthma or COPD- Yes 1814 (11.9) 1161 (11.0) 569 (13.3)
Chronic renal failure- Yes 555 (3.6) 272 (2.6) 252 (5.9)
Peripheral vascular disease- Yes 587 (3.9) 358 (3.4) 208 (4.9)
Previous Angina- Yes 2758 (17.8) 1501 (14.0) 1133 (26.3)
Previous PCI- Yes 1061 (6.9) 670 (6.3) 357 (8.3)
Previous CABG- Yes 790 (5.1) 374 (3.5) 395 (9.1)
Hypertension- Yes 6389 (41.0) 4186 (38.8) 2007 (46.3)
OHCA  presenting characteristics
Time point of cardiac arrest, n (%)
Before ambulance arrival 10,533 (60.1) 6371 (52.3) 3747 (78.7)
After  ambulance arrival 7004 (39.9) 5811 (47.7) 1013 (21.3)
Cardiac arrest rhythm, n (%)
Asystole 885 (5.4) 422 (3.7) 388 (8.8)
PEA  837 (5.1) 444 (3.8) 353 (8.0)
VF/VT  14,778 (89.6) 10,691 (92.5) 3665 (83.2)
Serum glucose (mmol/L)- Mean (SD) 10.94 (5.00) 10.92 (4.91) 10.99 (5.23)
Creatinine (micromol/L)- Mean (SD) 108.12 (55.72) 104.12 (49.86) 117.80 (67.17)
Left  Ventricular Ejection Fraction, n (%)
Good 2783 (36.4) 1873 (34.3) 858 (41.4)
Moderate 3131 (40.9) 2347 (43.0) 744 (35.9)
Poor  1736 (22.7) 1233 (22.6) 469 (22.6)
Haemoglobin (g/dL)- Mean (SD) 13.57 (2.03) 13.69 (2.01) 13.27 (2.05)
Serum cholesterol (mmol/L)- Mean (SD) 4.80 (1.51) 4.91 (1.47) 4.46 (1.64)
Admission diagnosis, n (%)
Deﬁnite MI  – anterior infarction 3897 (27.0) 3809 (40.6) 78 (1.7)
Deﬁnite MI  – other infarction site 3639 (25.2) 3463 (36.9) 159 (3.5)
Other  initial diagnosis 6883 (47.7) 2105 (22.4) 4306 (94.8)
Admission systolic BP (mmHg)- Mean (SD) 125.69 (29.17) 124.95 (28.75) 127.27 (29.86)
ECG  that determined treatment, n (%)
ST elevation or LBBB 12,220 (71.9) 12,220 (100.0%) 0 (0%)
ST  depression/T wave changes only 2325 (13.7) 0 (0%) 2325 (48.7%)
Other  change/No acute changes 2447 (14.4) 0 (0%) 2447 (51.3%)
Admission heart rate (/minute)- Mean (SD) 89.22 (24.79) 88.55 (24.10) 90.54 (26.12)
Daytime hospital admission (8am to <8pm)- n (%) 11,741 (66.7%) 8083 (66.1%) 3272 (68.6%)
Killip  Class, n (%)
Basal crepitations and/or elevated venous pressure 796 (13.8) 517 (12.1) 269 (18.5)
Pulmonary oedema 317 (5.5) 228 (5.3) 89 (6.1)
Cardiogenic shock 1029 (17.9) 853 (20.0) 169 (11.6)
No  evidence of heart failure 3612 (62.8) 2665 (62.5) 927 (63.8)
Mini-Grace score- Mean (SD) 173 (28.37) 174 (27.92) 172 (29.38)
Care  pathway variables
Hospital volume (OHCA cases per year)- n (%)
1  to 10 cases 7984 (45.4) 4900 (40.1) 2673 (56.0)
11  to 24 cases 6516 (37.0) 4799 (39.3) 1565 (32.8)
25  to 82 cases 3104 (17.6) 2521 (20.6) 534 (11.2)
Hospital pPCI capability- n (%)
pPCI capable 7800 (44.3) 6514 (53.3) 1205 (25.3)
pPCI  incapable 9804 (55.7) 5706 (46.7) 3567 (74.7)
EMS  response time (Minutes)- Mean (SD) 11.53 (11.82) 12.03 (12.42) 10.29 (10.11)
EMS  travel distance (Kilometres)- Mean (SD) 11.24 (10.08) 11.96 (10.50) 9.67 (8.88)
Admitting consultant, n (%)-
Cardiologist 10,680 (61.8) 8480 (70.6) 2008 (42.8)
Other  consultant 6603 (37.5) 3534 (29.4) 2689 (57.2)
Cardiological care during admission- yes- n (%) 11,960 (90.7) 8797 (93.3) 2975 (85.0)
Admission Ward, n (%)
CCU 8872 (51.0) 6984 (57.9) 1683 (35.4)
Cardiac ward − non CCU 500 (2.9) 366 (3.0) 123 (2.6)
Intensive therapy unit 6154 (35.4) 3666 (30.4) 2290 (48.2)
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Table  1 (Continued)
All cases (n = 17,604)a STEMI (n = 12,220)a NSTEACS (n = 4772)a
General medical ward or Other 1534 (8.8) 868 (7.2) 558 (11.8)
Died  in Emergency Department 340 (1.9) 176 (1.5) 94 (2.0)
Place  where ECG performed, n (%)
Pre-hospital 11,053 (75.7) 8253 (79.2) 2659 (67.0)
In  hospital 3551 (24.3) 2162 (20.8) 1311 (33.7)
Reperfusion treatment and timing, n (%)
None 5633 (37.1) 2048 (18.3) 2350 (90.1)
Thrombolysis (early) 1080 (7.1) 1053 (9.4) 20 (0.5)
Thrombolysis (late) 1930 (12.7) 1832 (16.4) 85 (2.3)
Thrombolysis (time missing) 370 (2.4) 314 (2.8) 40 (1.1)
pPCI  (early) 4424 (29.2) 4293 (38.5) 122 (3.3)
pPCI  (late) 1063 (7.0) 994 (8.9) 65 (1.7)
pPCI  (time missing) 673 (4.4) 631 (5.7) 36 (1.0)
Discharge care variables
Discharge Diagnosis, n (%)
Acute coronary syndrome 16,476 (95.1) 11,710 (97.5) 4232 (89.8)
Other  diagnosis 843 (4.9) 304 (2.5) 483 (10.2)
Echocardiography- yes/planned- n (%) 11,140 (73.8) 7902 (75.2) 2990 (72.6)
Outcomes
Survival to hospital discharge-n (%) 12,557 (71.3) 9049 (74.1) 3184 (66.7)
Discharged without neurological deﬁcit- n (%)‡ 9041 (59.1) 6736 (62.9) 2081 (51.4)
CABG- Coronary Artery Bypass Graft; CCU- Cardiac Care Unit; COPD- Chronic Obstructive Pulmonary Disease; ECG- Electrocardiogram; EMS- Emergency Medical Service;
LBBB-  Left Bundle Branch Block; MI-  Myocardial Infraction; OHCA- Out-of-Hospital Cardiac Arrest; (p)PCI- (primary) Percutaneous Coronary Intervention; PEA- Pulseless
Electrical Activity; VF- Ventricular Fibrillation; VT- Ventricular Tachycardia.
a The n for each variable is the total group size minus the number of missing cases (see 
in  the sub-groups.
‡ Neurological outcome data available for 15,286 patients.
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in a non-shockable OHCA rhythm (Table 1). NSTEACS patients wereFig. 3. Percentage of patients admitted to pPCI capable centres by year.
Demographic and medical history variables explained little
ariation, with age (R2 = 0.060) having the highest R2 value (Sup-
lementary Data Table S2). A greater degree of variation was
xplained by some OHCA presenting characteristic and care path-
ay variables, such as OHCA rhythm (R2 = 0.104), serum glucose
R2 = 0.083), and admission ward (R2 = 0.178). Little variation was
xplained by OHCA hospital volume (R2 = 0.006), hospital pPCI
apability (R2 = 0.003) and reperfusion therapy (R2 = 0.042). The
djusted analysis explained 36.1% (R2 = 0.361) of the variation
cross the dataset (Table 2).Supplementary information). 612 cases were missing STEMI status, so not included
Factors inﬂuencing mortality
Across the whole cohort, after co-variate adjustment, demo-
graphic factors associated with increased mortality included
increasing age and social deprivation (Table 2). Other factors associ-
ated with higher mortality included female gender, history of heart
failure, increasing blood glucose, OHCA prior to EMS  arrival, and
STEMI or LBBB on the initial ECG. Hypertension, hypercholestero-
laemia, and a shockable OHCA rhythm were associated with lower
mortality.
Health service factors that did not inﬂuence mortality include
time of day of admission, hospital OHCA volume, EMS  response
time, and ﬁrst ECG location. Admission to a pPCI capable hospital
was associated with higher mortality (OR 1.26, 95% CI 1.05–1.53).
A supplementary analysis identiﬁed case-mix differences between
patients treated in pPCI capable and non-pPCI capable hospitals.
More patients initially admitted to a pPCI capable hospital pre-
sented in a shockable OHCA rhythm (92.8% v 86.9%), had a STEMI
diagnosis, (84.4% v 61.5%), and were in cardiogenic shock (21.9% v
5.7%) (Supplementary Data Table S3).
Hospital admission under a cardiologist (OR  0.73, 95% CI
0.64–0.82) was associated with lower mortality. Early reperfusion
treatment was the key modiﬁable health service factor associated
with reduced mortality (early thrombolysis 0.67, 95% CI 0.52–0.86;
early pPCI OR 0.70, 95% CI 0.60–0.83).
STEMI and NSTEACS cohorts
Adjusted models restricted to STEMI and NSTEACS cohorts
explained a similar degree of variation as the primary analysis
(STEMI: R2 = 0.354; NSTEMI R2 = 0.365) (Table 2). Compared to
STEMI patients, NSTEACS patients were older (mean age 68.3 v 63.9
years), had more co-morbidities, and were more likely to presentless likely to be admitted to a high-volume OHCA (11.2% v 20.6%)
or pPCI capable (25.3% v 53.3%) hospital, and less likely to receive
reperfusion therapy (9.9% v 81.7%).
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Table 2
Multiviariate analysis across all cases, STEMI cases and NSTEACS cases.
Odds ratio of in-hospital mortality (95% conﬁdence intervals), p-value*
All cases (n = 17,604) STEMI (n = 12,220) NSTEACS (n = 4772)
Demographic variables
Age (Years)** 1.046 (1.042, 1.051), <0.001 1.048 (1.043, 1.054), <0.001 1.048 (1.040, 1.056), <0.001
Gender Male  0.877 (0.786, 0.979), 0.019 0.921 (0.806, 1.052), 0.226 0.758 (0.621, 0.925), 0.006
Femalea
Ethnicity Asian 1.022 (0.804, 1.299), 0.860 0.961 (0.725, 1.275), 0.783 1.167 (0.702, 1.939), 0.551
Black  0.939 (0.602, 1.464), 0.780 0.833 (0.509, 1.364), 0.468 1.059 (0.511, 2.198), 0.877
Other  0.991 (0.723, 1.358), 0.956 1.023 (0.726, 1.440), 0.898 0.871 (0.417, 1.819), 0.713
Whitea
Index of multiple deprivation score** 1.005 (1.002, 1.008), 0.003 1.002 (0.998, 1.006), 0.323 1.010 (1.004, 1.016), 0.002
Medical  history variablesa
Smoking status- ever smoked 0.903 (0.812, 1.004), 0.059 0.875 (0.765, 1.000), 0.050 1.009 (0.830, 1.226), 0.927
Diabetes  status- Diabetic 1.125 (0.981, 1.290), 0.092 1.162 (0.976, 1.384), 0.091 1.123 (0.890, 1.416), 0.329
Hypercholesterolaemia 0.692 (0.615, 0.779), <0.001 0.669 (0.577, 0.776), <0.001 0.684 (0.551, 0.850), 0.001
Heart  failure 1.318 (1.074, 1.618), 0.008 1.584 (1.178, 2.128), 0.002 1.192 (0.874, 1.624), 0.267
Cerebrovascular disease 1.299 (1.097, 1.537), 0.002 1.075 (0.858, 1.348), 0.529 1.703 (1.294, 2.241), <0.001
Previous  MI 1.028 (0.900, 1.173), 0.685 0.997 (0.836, 1.188), 0.971 1.118 (0.899, 1.39), 0.327
Asthma  or COPD 1.247 (1.087, 1.431), 0.002 1.228 (1.030, 1.463), 0.022 1.246 (0.975, 1.591), 0.079
Chronic  renal failure 1.065 (0.841, 1.350), 0.601 0.864 (0.613, 1.219), 0.406 1.390 (0.969, 1.995), 0.073
Peripheral  vascular disease 1.517 (1.208, 1.904), <0.001 1.723 (1.286, 2.309), <0.001 1.338 (0.903, 1.981), 0.146
Previous  angina 1.011 (0.885, 1.156), 0.867 1.037 (0.869, 1.239), 0.684 0.926 (0.743, 1.154), 0.494
Previous  PCI 1.025 (0.840, 1.251), 0.806 1.051 (0.815, 1.356), 0.700 0.923 (0.652, 1.305), 0.649
Previous  CABG 0.996 (0.811, 1.222), 0.966 1.189 (0.894, 1.583), 0.235 0.830 (0.607, 1.135), 0.244
Hypertension 0.865 (0.784, 0.955), 0.004 0.849 (0.752, 0.960), 0.009 0.866 (0.723, 1.038), 0.120
OHCA  presenting characteristics
Time point of cardiac arrest After EMS  arrive 0.492 (0.441, 0.548), <0.001 0.483 (0.425, 0.548), <0.001 0.424 (0.331, 0.544), <0.001
Before  EMS  arrivala
Cardiac arrest rhythm PEA 0.847 (0.658, 1.088), 0.194 0.730 (0.507, 1.051), 0.091 0.846 (0.573, 1.248), 0.399
VF/VT  0.217 (0.180, 0.262), <0.001 0.189 (0.145, 0.247), <0.001 0.231 (0.172, 0.310), <0.001
Asystolea
Serum glucose** 1.109 (1.096, 1.122), <0.001 1.113 (1.097, 1.130), <0.001 1.103 (1.081, 1.126), <0.001
Haemoglobin** 0.912 (0.878, 0.946), <0.001 0.920 (0.884, 0.958), <0.001 0.892 (0.842, 0.945), <0.001
Serum  cholesterol** 0.956 (0.906, 1.010), 0.108 0.953 (0.892, 1.017), 0.150 0.980 (0.910, 1.056), 0.595
Admission  diagnosis Other diagnosis 0.876 (0.750, 1.024), 0.097 1.005 (0.850, 1.188), 0.956 0.586 (0.329, 1.043), 0.069
Deﬁnite MI  – other infarct site 1.022 (0.890, 1.173), 0.762 1.029 (0.898, 1.179), 0.679 1.192 (0.603, 2.358), 0.614
Deﬁnite MI  – anterior infarcta
Admission systolic blood pressure Linear term*** -42.15 (-48.35, −35.96), <0.001 -33.76 (-40.3, −27.3), <0.001 -23.45 (-29.6, −17.3), <0.001
Quadratic term*** 17.68 (11.79, 23.57), <0.001 16.96 (11.00, 22.92), <0.001 6.42 (0.46, 12.38), 0.035
ECG  that determined treatment ST elevation or LBBB 1.592 (1.364, 1.858), <0.001 Only ST elevation/LBBB patients included in this analysis Data not included
ST  depression/T wave changes only 0.907 (0.775, 1.062), 0.227 0.859 (0.728, 1.014), 0.073
Other  change/No acute changesa
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Admission heart rate** 1.005 (1.004, 1.007), <0.001 1.006 (1.004, 1.008), <0.001 1.005 (1.002, 1.008), 0.004
Time  of the day of admission 8pm to <8am (night) 1.091 (0.994, 1.196), 0.066 1.037 (0.926, 1.163), 0.528 1.203 (1.010, 1.433), 0.038
8am  to <8pm (day)a
Admission year** Slope (2003–2008) 0.947 (0.895, 1.002), 0.057 0.996 (0.931, 1.066), 0.916 0.885 (0.810, 0.968), 0.008
Slope  (2009–2015) 1.044 (1.009, 1.079), 0.012 1.038 (0.998, 1.081), 0.065 1.016 (0.953, 1.082), 0.632
Care  pathway variables
Hospital volume (OHCA cases per year) 0–10 cases 1.033 (0.723, 1.474), 0.860 1.229 (0.904, 1.670), 0.189 0.688 (0.386, 1.229), 0.207
11–24  cases 1.259 (0.877, 1.808), 0.211 1.242 (0.926, 1.667), 0.148 0.948 (0.534, 1.681), 0.854
25  to 82 casesa
Hospital pPCI capability pPCI capable pPCI incapablea 1.262 (1.043, 1.527), 0.017 1.584 (1.261, 1.989), <0.001 0.849 (0.605, 1.190), 0.342
EMS  response time (Mins)** 0.999 (0.995, 1.004), 0.776 1.000 (0.995, 1.005), 0.996 0.997 (0.987, 1.007), 0.589
EMS  travel distance (Km)** 0.994 (0.989, 0.999), 0.024 0.992 (0.986, 0.998), 0.012 0.997 (0.987, 1.008), 0.612
Admitting  consultant Cardiologist 0.725 (0.641, 0.822), <0.001 0.794 (0.680, 0.927), 0.003 0.615 (0.494, 0.766), <0.001
Other  consultanta
Admission ward Intensive therapy unit 3.741 (3.331, 4.202), <0.001 3.267 (2.852, 3.742), <0.001 5.239 (4.107, 6.685), <0.001
Died  in ED Not estimable Not estimable Not estimable
General ward or other 3.452 (2.941, 4.051), <0.001 3.549 (2.884, 4.368), <0.001 3.575 (2.642, 4.838), <0.001
Cardiac ward − non CCU 1.212 (0.841, 1.748), 0.302 1.148 (0.728, 1.810), 0.552 1.588 (0.861, 2.929), 0.138
CCUa
Place where ECG performed In hospital 1.125 (0.970, 1.304), 0.120 1.127 (0.956, 1.329), 0.154 1.088 (0.878, 1.348), 0.439
Pre  hospitalaa
Reperfusion treatment and timing Thrombolysis (early) 0.672 (0.523, 0.863), 0.002 0.714 (0.550, 0.926), 0.011 0.501 (0.121, 2.071), 0.340
Thrombolysis (late) 0.860 (0.723, 1.023), 0.088 0.893 (0.741, 1.075), 0.231 0.939 (0.480, 1.837), 0.854
Thrombolysis (time missing) 0.954 (0.702, 1.298), 0.766 0.940 (0.672, 1.315), 0.717 1.248 (0.500, 3.117), 0.635
pPCI  (early) 0.704 (0.600, 0.826), <0.001 0.618 (0.518, 0.737), <0.001 0.802 (0.430, 1.498), 0.490
pPCI  (late) 0.941 (0.773, 1.145), 0.542 0.836 (0.675, 1.035), 0.100 0.967 (0.479, 1.952), 0.926
pPCI  (time missing) 0.690 (0.532, 0.893), 0.005 0.610 (0.463, 0.802), <0.001 1.496 (0.593, 3.773), 0.393
Nonea
Random Effects estimate (R squared, Akaike Information Criterion) 0.215b (0.361b, 14134b) 0.118b (0.354b, 9471b) 0.378b (0.365b, 4133b)
CABG- Coronary Artery Bypass Graft; CCU- Cardiac Care Unit; COPD- Chronic Obstructive Pulmonary Disease; ECG- Electrocardiogram; ED- Emergency Department; EMS- Emergency Medical Service; LBBB- Left Bundle Branch
Block;  MI-  Myocardial Infraction; OHCA- Out-of-Hospital Cardiac Arrest; (p)PCI- (primary) Percutaneous Coronary Intervention; PEA- Pulseless Electrical Activity; VF- Ventricular Fibrillation; VT- Ventricular Tachycardia.
* Values describe odds ratio (95% conﬁdence interval), p value unless stated.
** Per whole unit increase.
*** Estimates on the logarithmic scale.
a Reference category (Medical History variables compared with absence of condition).
b Median from 25 datasets.
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Admission to pPCI hospital was associated with higher mortal-
ty in STEMI (OR 1.58, 95% CI 1.26–1.99) but not in NSTEACS (OR
.85, 95% CI 0.61–1.19) patients. Reperfusion therapy was associ-
ted with lower mortality in STEMI patients, but not in NSTEACS
atients (e.g. early pPCI STEMI OR 0.62, 95% CI 0.52–0.74; NSTEACS
R 0.80, 95% CI 0.43–1.50). Compared to daytime, overnight admis-
ion was associated with higher mortality in the NSTEACS (OR 1.20,
5% CI 1.01–1.43), but not the STEMI (OR 1.04, 95% CI 0.93–1.16)
roup.
ensitivity analyses
Sensitivity analyses for the complete case (n = 2284, 13.0%),
003–2008 (n = 6075, 34.5%), and 2009–2015 (n = 11,529, 65.5%)
ohorts, explained a similar degree of variation to the primary anal-
sis (Supplementary Data Table S4). Findings of these analyses were
enerally consistent with the primary analysis, albeit conﬁdence
ntervals were typically wider. Point estimates for most reperfusion
reatments in the complete case cohort indicated higher mortality,
hich may  reﬂect a selection bias inasmuch as a complete dataset
s likely easier to collect in patients that die.
iscussion
In this analysis of 17,604 OHCA patients with ACS, admitted alive
o 239 UK hospitals, just under three in ten died in hospital. Across
he 94 hospitals contributing at least 60 cases, we identiﬁed wide
ariation in inter-hospital mortality. Modelling explained approxi-
ately one third of this variation. Over the 12-year study period, we
bserved changes in clinical practice, including increased admis-
ion of patients to pPCI capable hospitals and high-volume OHCA
ospitals, and increased use of reperfusion treatment. The key mod-
ﬁable factor associated with lower hospital mortality in STEMI
atients was early reperfusion treatment.
Previous studies of OHCA have been inconsistent as to the asso-
iation between hospital facilities, OHCA volume and outcome,
hich may  be partly reﬂect variability in how these concepts are
eﬁned across the literature [15–18]. In contrast to the ﬁndings
f a recent analysis of the American Cardiac Arrest Registry to
nhance Survival dataset, we unexpectedly observed an associ-
tion between admission to a pPCI capable hospital and higher
ortality [19]. This ﬁnding may  be partly explained by case-mix
ifferences between patients treated in pPCI and non-pPCI capable
ospitals. In particular, a higher proportion of patients in cardio-
enic shock were admitted to pPCI capable hospitals, although the
egree of missingness within this variable precluded its imputation
nd modelling.
The decisions by paramedics as to the most appropriate hospital
o which to transfer a patient for ongoing treatment may  be inﬂu-
nced by patient condition, hospital facilities, patient preference,
ocal care pathways, and transfer time. Increased transfer time may
ncrease the risk of clinical adverse events, but, in keeping with
revious studies, we observed no harm associated with increasing
ransport distance [15,20].
In line with previous ACS studies, we observed an association
etween increasing admission blood glucose and higher mortal-
ty [21,22]. Active management of hyperglycaemia in ACS has been
ssociated with improved outcome [23], and is recommended in
nternational guidelines [24,25]. Our study did not analyse the med-
cal management of hyperglycaemia, but our ﬁndings highlight a
eed for further research on this potentially modiﬁable clinical
arameter.
Our ﬁndings indicate the widespread implementation of
vidence-based guidelines for the immediate management of
yocardial infarction following OHCA [24,25]. Most STEMI patientson 124 (2018) 49–57
(81.7%) and some NSTEACS patients (9.9%) received reperfusion
therapy. In keeping with clinical trial data, early reperfusion treat-
ment was  associated with lower mortality in STEMI patients
[26,27].
We used the MINAP dataset to analyse outcomes in OHCA due
to ACS. The key advantages to this dataset are national coverage
and longevity. For the purpose of this study, its key limitation was
that it does not capture key variables relevant to OHCA such as
location (public v private) and bystander CPR. Future studies may
consider enriching MINAP data through linkage with other relevant
UK datasets, such as the OHCA outcomes project and intensive care
case mix  programme [2,28]. The OHCA outcomes project could pro-
vide key data on OHCA characteristics, but was established only
in 2013 thereby limiting the opportunity for linkage. The inten-
sive care case mix  programme was  established in the 1990s, but
only approximately one in three patients in this study was admit-
ted to the intensive care unit and the case mix  programme does
not directly collect provision of targeted temperature management
although this may  be derived from other variables [29].
Our study has the limitations inherent in all observational stud-
ies. In particular, despite its large size and use of complex statistical
analyses, our ﬁndings may  be affected by unmeasured residual con-
founders. A key challenge in analysing audit datasets such as MINAP
is the management of missing data [13]. Whilst we used sophisti-
cated techniques to impute data, the degree of missingness in some
important variables, such as Killip class, precluded this approach.
Finally, there is known inter-hospital variation in methods used to
identify patients for reporting to MINAP, particularly in NSTEACS
patients, which may  lead to selection bias [11].
Conclusions
This large cohort study of patients with OHCA due to ACS found
evidence of marked variation in mortality between hospitals, which
was not fully explained by modelled patient and health service
factors. Whilst we observed no association between cardiac arrest
centre characteristics (volume, pPCI capability) and lower mortal-
ity, the early use of reperfusion treatment, which is likely to be
available only in such centres, was associated with lower mortality
in STEMI patients.
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